高强度聚焦超声治疗子宫肌瘤后生殖结局的系统综述
本系统综述纳入21项研究,总结MRI引导(MR-HIFU)与超声引导(USgHIFU)高强度聚焦超声治疗子宫肌瘤后的妊娠、活产、流产及剖宫产率等生殖结局。MR-HIFU报告124例妊娠,妊娠率 retrospectively 收集为7%–36%,最大前瞻性注册研究中流产率为39%;USgHIFU报告366例妊娠,唯一前瞻性研究报告妊娠率47%、流产率11%。作者认为现有异质性数据下HIFU后生殖结局似乎不劣于当前标准治疗,但需随机对照试验提供充分证据。
要点
- MR-HIFU后报告124例妊娠,妊娠率仅回顾性收集,范围7%–36%,最大前瞻性注册研究流产率39%。
- USgHIFU后报告366例妊娠,唯一前瞻性研究报告妊娠率47%、流产率11%。
- 两种HIFU后均无子宫破裂报告,但均有前置胎盘发生(MR-HIFU 2例,USgHIFU 6例)。
核心结论
- 基于当前异质性数据,HIFU后的生殖结局似乎不劣于当前标准治疗,但需随机对照试验比较HIFU与标准治疗的生殖结局以提供充分证据。
研究设计与样本
- 系统综述,检索并纳入21项经同行评议的全文研究,报告HIFU治疗子宫肌瘤后的生殖结局。
- 干预包括MRI引导(MR-HIFU)或超声引导(USgHIFU)的高强度聚焦超声,结局包括妊娠率、活产率、流产率、剖宫产率、受孕时间、并发症及可能预后因素。
诊断标准与关键数值
- MR-HIFU:14项研究报告124例妊娠,妊娠率回顾性收集范围为7%–36%,最大前瞻性注册研究中流产率为39%,报告2例前置胎盘、无子宫破裂。
- USgHIFU:报告366例妊娠,唯一前瞻性研究报告妊娠率47%、流产率11%,报告1例胎儿宫内死亡、6例前置胎盘、无子宫破裂。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 现有数据异质性大。
- 妊娠率仅通过回顾性方式收集,范围为7%–36%。
- 大多数研究未提供年龄等可能预后因素。
- 需随机对照试验比较HIFU与标准治疗的生殖结局以提供充分证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Myomectomy is currently the gold standard for the treatment of uterine fibroids in women who desire pregnancy. However, this surgical fibroid removal has a long convalescence. Promising alternatives may be non-invasive High Intensity Focused Ultrasound (HIFU) under either MRI (MR-HIFU) or ultrasound guidance (USgHIFU). In this systematic review, an overview is provided of reproductive outcomes after these two relatively new ablation techniques.
METHOD: A systematic literature search was performed to identify studies reporting reproductive outcomes after HIFU treatment of fibroids. Only peer reviewed, full papers were included. Outcomes included pregnancy-, live-birth- miscarriage and caesarian section rate, time to conceive, reported complications, and possible prognostic factors.
RESULTS: In total 21 studies were included. Fourteen studies reported 124 pregnancies after MR-HIFU. Two placenta previas and no uterus ruptures were reported. Pregnancy rates were only retrospectively collected and ranged between 7% and 36%. Miscarriage rate in the oldest and largest prospective registry was 39%. After USgHIFU 366 pregnancies were reported with one fetal intrauterine death, six placenta previas and no uterus ruptures. The only prospective study reported a pregnancy rate of 47% and a miscarriage rate of 11%. Possible prognostic factors like age were not available in most studies.
CONCLUSIONS: Based on the heterogeneous data currently available, reproductive outcomes after HIFU appear non-inferior to outcomes after the current standard of care. However, a (randomized) controlled trial comparing reproductive outcomes after HIFU and standard care is necessary to provide sufficient evidence on the preferred fibroid treatment for women with a pregnancy wish.
引用
- Anneveldt KJ, van 't Oever HJ, Nijholt IM, et al. Systematic review of reproductive outcomes after High Intensity Focused Ultrasound treatment of uterine fibroids. Eur J Radiol. 2021. PMID: 34116454. doi:10.1016/j.ejrad.2021.109801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。